In the new study, Rodriguez and colleagues analyzed electronic health records from more than 41,000 adults who were overweight or had obesity and had been prescribed one of the two drugs for the first time
The active ingredient in Foundayo, orforglipron, is also being studied as a potential treatment for type 2 diabetes, obstructive sleep apnea, osteoarthritis knee pain, and other conditions
Consistent with this expectation, Argyrakopoulou et al reported that in a cohort of obese individuals treated with liraglutide, the dominant change was a reduction in fat mass, accompanied by only a minimal decline in lean mass
Colorado Springs residents interested in more potent weight control methods can consider this once-weekly injection, which has shown an average weight loss of 20.9% in clinical settings
M.HayhoeA.et al
Some of those drugs, such as a class that overrides the bodys natural limit on muscle growth, are already banned by WADA